Ruxolitinib 1.5% Cream
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ruxolitinib 1.5% Cream, covering 2025-03-24 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus [Phase 2]